How to buy Adherium shares
Own Adherium shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Adherium Limited is a medical devices business based in Australia. Adherium shares (ADR) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Adherium has a trailing 12-month revenue of around $2.2 million.
How to buy shares in Adherium
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Adherium. Find the share by name or ticker symbol: ADR. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Adherium reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Adherium. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Adherium share priceUse our graph to track the performance of ADR stocks over time.
Adherium shares at a glance
|52-week range||$0.011 - $0.051|
|50-day moving average||$0.0232|
|200-day moving average||$0.0274|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.068|
Compare share trading platforms
Is it a good time to buy Adherium stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Adherium price performance over time
|1 month (2021-03-19)||0.018|
|Revenue TTM||$2.2 million|
|Gross profit TTM||$1.4 million|
|Return on assets TTM||-122.45%|
|Return on equity TTM||-540.91%|
|Market capitalisation||$13.6 million|
TTM: trailing 12 months
Adherium share dividends
We're not expecting Adherium to pay a dividend over the next 12 months.
Adherium share price volatility
Over the last 12 months, Adherium's shares have ranged in value from as little as $0.011 up to $0.051. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Adherium's is 2.1835. This would suggest that Adherium's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. It offers Hailie, an asthma and COPD medication adherence solution for patients with chronic respiratory diseases. The company also provides a range of smart device sensors for respiratory medications, such as Bluetooth enabled Hailie sensors wrap around a patient's existing inhalers and automatically send usage data to their smartphone; and Hailie app that enables patients, caregivers, and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. It offers its digital health solutions to patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company has a collaboration with HGE Health in COPD. The company was founded in 2001 and is headquartered in Auckland, New Zealand.
Frequently asked questions
More guides on Finder
Kiwi broker Sharesies launches 1 cent ASX share trading in Australia
You can now invest as little as 1 cent into Australian, NZ and US shares. Here's why that's a game changer.
How to invest in the Didi Chuxing IPO from Australia
Everything we know about the Didi Chuxing IPO, plus information on how to buy in.
How to buy Robinhood stock from Australia
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
How to build a DIY Raspberry Pi arcade machine for retro gaming
We explain everything you need to make your own retro arcade machine, built around the super-flexible Raspberry Pi.
International money transfer services
Beat the banks, find the best exchange rates and avoid fees when you send money abroad from Australia.
How to sell shares in Australia
All the key info you need to know to sell shares you inherited or received as a gift.
How to buy Roblox (RBLX) shares from Australia
Steps to owning and managing Roblox shares.
How to buy Adherium shares
Steps to owning and managing Zebit shares.
Ask an Expert